The Australian Government announces Continuous Glucose Monitoring (CGM) Subsidy Initiative Expansion
Posted Mar 1, 2019.
The Australian Government is extending access to fully subsidised continuous glucose monitoring (CGM) products through the National Diabetes Services Scheme (NDSS) to now include eligible patients aged over 21 years with type 1 diabetes. Previously, only patients aged 21 years or under were eligible for subsidised CGM.
Both Dexcom G5 Mobile and Dexcom G4 PLATINUM Systems are now available to eligible patients who meet the criteria for one of the following groups:
- Children and young people under 21 years with type 1 diabetes
- People with type 1 diabetes aged 21 years or older who have valid concessional status and have a high clinical need
- Women with type 1 diabetes who are actively planning pregnancy, pregnant or immediately post-pregnancy
- Children and young people under 21 years with conditions very similar to type 1 diabetes who require insulin
Patients or healthcare professionals can visit www.ndss.com.au/CGM for more information.